Adem Koyuncu is double qualified as a lawyer and medical doctor and a partner in our Brussels and Frankfurt office. He is a chair of the firm's "Food, Drug & Device" practice group and also a member of our Compliance practice. Adem is recognized as a "leading lawyer for pharma and medical devices law" (JUVE).

Adem is a life sciences industry advisor with more than 25 years of professional experience. He has a broad practice that cuts across regulatory, compliance, IP, privacy and liability matters. Adem also provides strategic advice. He knows the life sciences sector also from his earlier work in the pharmaceutical industry and as a medical doctor. He represents clients before courts and authorities and assists them in contract negotiations, investigations and transactions. For years, Adem is listed in various lawyer rankings.

See some Accolades from Clients and Surveys:

"Adem Koyuncu is one of the most intelligent lawyers I know." (Legal 500 2023)
"He is one of the most detail-oriented and client-focused partners I have ever encountered." (Client, Chambers 2021)
"Great professional and human competence, good team player." (Client/Adverse Party, JUVE 2022)
"I find him to be one of the most pragmatic regulatory lawyers. He was a doctor before a lawyer, has been in-house, worked on lots of stuff that I have to handle in-house, which helps when getting advice. He is really good at saying it's a complex situation and your best option is to do this." (Chambers 2022)
"He always comes through with extremely helpful advice. He brings a unique understanding and experience to his practice as both a lawyer and medical doctor." (Chambers 2021)
"He is an excellent dispute resolution lawyer and advises at the highest level, including, in particular, strategic advice." (Legal 500 2023)
"He is very sharp and quick, while at the same time having a good sense of humor and nerves of steel. Very pleasant to work with." (Legal 500 2022)
He is described as "versatile competent, reliable and high quality" (JUVE 2021) and "incredibly fast." (JUVE 2018)
Provides advice at "an outstanding level." (Legal 500 2015)
"Very strong negotiation skills." (JUVE 2011)
Clients appreciate his "very broad knowledge and long-standing expertise" (JUVE 2021/22) and that "he is approachable, knowledgeable and really easy to talk to over the various issues. He is calm and has seen most problems before." (Chambers 2020)
Peer lawyers described him as "highly competent" and a "very good and pleasant lawyer” (JUVE 2014) and as "the off-label-guru, substantively very good, creative." (JUVE 2022)

Adem is the author of numerous publications (e.g., in leading books on pharma law, product liability and clinical trials) and frequent speaker at different events. As such, he will soon speak at following events:

Webinar “Germany Life Sciences Update – Spotlight: Pharmaceutical Advertising“ (February 26, 2026)
Webinar “Most Favored Nation (MFN) Principle - Focus Pharma” (June 17/ 2026)